An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas

British Journal of Cancer

Volumn 74, Issue 10, 1996, Pages 1620-1626

  Takeda, O ^a   Handa, M ^a   Uehara, T ^a   Maseki, N ^a   Sakashita, A ^a   Sakurai, M ^a   Kanda, N ^b   Arai, Y ^c   Kaneko, Y ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Loss of heterozygosity; Neuroblastoma; NM23H1; Prognostic factors

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CHILD; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 1P; CONTROLLED STUDY; DIPLOIDY; GENE LOSS; GENE NUMBER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

EID: 0029854513     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.598     Document Type: Article

References (28)

1. BEVILACQUA G, SOBEL ME, LIOTTA LA AND STEEG PS. (1989). Association of low nm23 RNA levels in human primary infiltration ductal breast carcinomas with lymph-node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49, 5185-5190.
2. CARON H. (1995). Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med. Pediatr. Oncol., 24, 215-221.
3. CHANG, CL, ZHU X, THORAVAL DH, UNGAR D, RAWWAS J, HORA N, STRAHLER JR AND HANASH SM. (1994). nm23-H1 mutation in neuroblastoma. Nature, 370, 335-336.
4. EVANS AE, D'ANGIO DJ AND RANDOLPH J. (1971). A proposed staging for children with neuroblastoma. Cancer, 27, 374-378.
5. FEINBERG AP AND VOGELSTEIN B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13.
6. FONG CT, DRACOPOLI NC, WHITE PS, MERRILL PGT, GRIFFITH RC, HOUSMAN DE AND BRODEUR GM. (1989). Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc. Natl Acad. Sci. USA, 86, 3753-3757.
7. FONG CT, WHITE PS, PETERSON K, SAPIENZA C, CAVENEE WK, KERM SE, VOGELSTEIN B, CANTOR AB, LOOK AT AND BRODEUR GM. (1992). Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res., 52, 1780-1785.
8. GEHAN E. (1965). A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika, 52, 203-224.
9. GILLES AM, PRESECAN E, VONICA A AND LASCU I. (1991). Nucleoside diphosphate kinase from human erythrocytes. J. Biol. Chem., 266, 8784-8789.
10. HAILAT N, KEIM DR, MELHEM RF, ZHU X, ECKERSKORN C, BRODEUR GM, REYNOLDS CP, SEEGER RC, LOTTSPEICH F, STRAHLER JR AND HANASH SM. (1991). High levels of p19/ nm23 protein in neuroblastoma are associated with advanced stage disease and N-myc gene amplification. J. Clin. Invest., 88, 341-345.
11. HUMAN GENE MAPPING 11. (1991). Cytogenet. Cell Genet., 58, 1440-1569.
12. ISCN 1991. (1992). Guidelines for Cancer Cytogenetics: Supplement to an International System for Human Cytogenetic Nomenclature, Karger: Basle.
13. KAPLAN EL AND MEIER P. (1958). Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc., 53, 457-481.
14. LEONE A, SEEGER RC, HONG CM, HU YY, ARBOLEDA MJ, BRODEUR GM, STRAM D, SLAMON DJ AND STEEG PS. (1993). Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene, 8, 855-865.
15. MURAKAMI Y, HAYASHI K AND SEKIYA T. (1991). Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-stranded conformation polymorphism analysis. Cancer Res., 51, 3356-3361.
16. NAKAMURA Y, LATHROP M, O'CONNELL P, LEPPERT M, KAMBOH MI, LALOUEL JM AND WHITE R. (1989). Frequent recombination is observed in the distal end of the long arm of chromosome 14. Genomics, 4, 76-81.
17. OKADA K, URANO T, GOI T, BABA H, YAMAGUCHI A, FURUKAWA K AND SHIKU H. (1994). Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. Cancer Res., 54, 3979-3982.
18. PETO R AND PETO J. (1972). Asymptotically efficient rank invariant test procedures. J. R. Stat. Soc., (a), 135, 185-206.
19. SAWADA T, HIRAYAMA M AND NAKATA T. (1984). Mass screening for neuroblastoma in infants in Japan. Lancet, 2, 271-273.
20. SCHLEIERMACHER G, PETER M, MICHON J, HUGOT J, VIELH P, ZUCKER J, MAGDELENAT H, THOMAS G AND DELATTRE O. (1994). Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chrom. Cancer, 10, 275-281.
21. SRIVATSAN ES, YING KL AND SEEGER RC. (1993). Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chroms. Cancer, 7, 32-37.
22. STEEG PS, BEVILACQUA G, KOPPER L, THORGEIRSSON UP, TALMADGE JE, LIOTTA LA AND SOBEL ME. (1988). Evidence for a novel gene associated with low tumor-metastatic potential. J. Natl Cancer Inst., 80, 200-204.
23. SUZUKI T, YOKOTA J, MUGISHIMA H, OKABE I, OOKUNI M, SUGIMURA T AND TERADA M. (1989). Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res., 49, 1094-1098.
24. TAKAYAMA H, SUZUKI T, MUGISHIMA T, FUJISAWA T, OOKUNI M, SCHWAB M, GEHRING M, NAKAMURA Y, SUGIMURA T, TERADA M AND YOKOTA J. (1992). Deletion mapping of chromosome 14q and 1p in human neuroblastoma. Oncogene, 7, 1185-1189.
25. TAKEDA O, HOMMA C, MASEKI N, SAKURAI M, KANDA N, SCHWAB M, NAKAMURA Y AND KANEKO Y. (1994). There may be two tumor suppressor genes on chromosome 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom. Cancer, 10, 30-39.
26. URANO T, FURUKAWA K AND SHIKU H. (1993). Expression of nm23/NDP kinase proteins on the cell surface. Oncogene, 8, 1371-1376.
27. VARESCO L, CALIGO MA, SIMI P, BLACK DM, NARDINI V, CASARINO L, ROCCHI M, FERRARA G, SOLOMON E AND BEVILACQUA. (1992). The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with BglII. Genes Chrom. Cancer, 4, 84-88.
28. WEITH A, MARTINSSON T, CZIEPLUCH C, BRUDERLEIN S, AMLER LC, BERTHOLD F AND SCHWAB M. (1989). Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chrom. Cancer, 1, 159-166.